Ensign Peak Advisors
OLMA icon

Ensign Peak Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Ensign Peak Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
+96,782
New +$2.15M ﹤0.01% 771
2025
Q1 		– Sell
-18,849
Closed -$110K – 1713
2024
Q4 		$110K Hold
18,849
– – ﹤0.01% 1702
2024
Q3 		$225K Buy
18,849
+4,000
+27% +$51.1K ﹤0.01% 1687
2024
Q2 		$161K Buy
14,849
+850
+6% +$9.22K ﹤0.01% 1701
2024
Q1 		$158K Buy
+13,999
New +$181K ﹤0.01% 1713
2021
Q3 		– Sell
-9,800
Closed -$275K – 1870
2021
Q2 		$275K Buy
9,800
+3,200
+48% +$91.1K ﹤0.01% 1686
2021
Q1 		$219K Buy
+6,600
New +$283K ﹤0.01% 1721

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ensign Peak Advisors's OLMA Position: Q1 2026 in Review

Ensign Peak Advisors opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 96,782 shares worth $1.44M. The stake represents ﹤0.01% of the portfolio and ranks #771 among its holdings. This is a return to the name: Ensign Peak Advisors previously reported a position in OLMA as recently as Q4 2024.

Ensign Peak Advisors first reported a position in OLMA in Q1 2021 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Ensign Peak Advisors held 96,782 shares of Olema Pharmaceuticals worth $1.44M as of Q1 2026.
  • Olema Pharmaceuticals was a new Ensign Peak Advisors position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #771 holding.
  • Ensign Peak Advisors first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.